Mountain Hill Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668K Hold
2,655
0.38% 27
2026
Q1
$577K Sell
2,655
-125
-4% -$27.7K 0.34% 26
2025
Q4
$635K Hold
2,780
0.45% 22
2025
Q3
$644K Buy
2,780
+125
+5% +$25.5K 0.56% 20
2025
Q2
$493K Hold
2,655
0.41% 28
2025
Q1
$556K Sell
2,655
-53
-2% -$10.3K 0.54% 25
2024
Q4
$481K Buy
+2,708
New +$498K 0.49% 24

Other funds holding ABBV

Mountain Hill Investment Partners's ABBV Position: Q2 2026 in Review

Mountain Hill Investment Partners held its AbbVie (ABBV) position steady in Q2 2026 at 2,655 shares worth $668K. The position accounts for 0.38% of the portfolio, ranked #27.

Mountain Hill Investment Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mountain Hill Investment Partners held 2,655 shares of AbbVie worth $668K as of Q2 2026.
  • Mountain Hill Investment Partners left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.38% of Mountain Hill Investment Partners's portfolio in Q2 2026, its #27 holding.
  • Mountain Hill Investment Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mountain Hill Investment Partners's 13F filing for Q2 2026, filed 16 Jul 2026.